NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Syndicate Bio

Syndicate Bio

Private
Newark, DelawareHealthcare & Life Scienceshttps://www.syndicate.bio/

Last Round

Pre Seed

May 23, 2025

Total Funding Raised

$120,000

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Syndicate Bio is a biotechnology company that operates as a platform for genomics and precision medicine initiatives, with a primary focus on Africa.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Precision Medicine, Drug Discovery, Healthcare Analytics

Business Model

B2B

Customer Profile

Services & Consulting, Data as a Service, Revenue Share

AI Layer

Infrastructure

Keywords

genomic dataprecision medicinegenetic testingbiotechgenomicsdrug discoverydata as a serviceDaaSclinical researchgenomic infrastructurebiobankcomputational biologyhealthcare analyticsclinical oncology testinggenomic sequencing

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Syndicate Bio Comparables

Compare Syndicate Bio with similar companies based on industry and business-model similarity.

Syndicate Bio comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
MyAfroDNA
86%
IndyGeneUS Bio
85%
Centre for Molecular Biosciences & Genomics Limited
84%

Syndicate Bio Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Pre SeedMay 23, 2025
AcceleratorSep 9, 2024

Key People

Founding team and executive leadership

Abasi Ene-Obong

Founder And CEO

Founding Team

Syndicate Bio Investors

Notable investors and investment history

Syndicate Bio investors
InvestorRounds
AUDA-NEPADPre Seed
TechstarsPre Seed, Accelerator
Belal Badat VenturesAccelerator
Nubia CapitalAccelerator, Pre Seed
StoryHouse VenturesAccelerator, Pre Seed
UNT Health Science CenterAccelerator

Market signals

Structured signals derived from secondary market and firmographic data.

  • May 17, 2026

    Monthly visitors grew 99% MoM, reaching 3.9K.

  • Oct 7, 2025

    Launched Direct by Syndicate Bio, a genetic testing service for Africa.

Syndicate Bio Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Syndicate Bio Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Syndicate Bio's valuation, stock price, and market status.

Firmographic Details

HeadquartersNewark, Delaware
Employee Range18
Year Founded2023
Last FundingMay 23, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.